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Introduction
The ubiquitin ligase MDM2 negatively regulates the tumor 
suppressor protein p53 in normal cells by targeting it for deg-
radation.1,2 In stressed cells the MDM2-p53 equilibrium shifts 
towards dissociation as a result of post-translational modifica-
tions (PTM), e.g., phosphorylations. This leads to the accumu-
lation of p53 that triggers cell repair or apoptotic pathways.1,2 
Multiple phosphorylation sites have been identified on either 
partner of the p53-MDM2 complex including the transac-
tivation (TA) domain of p53 and the p53 binding N-terminal 
domain of MDM2. These regions have been well characterized 
and the role of phosphorylation in cellular regulation has been 
unambiguously described in references 3–7. However, the exact 
mechanisms underlying this regulation are still being unraveled. 
The first 24 amino acids of the p53 binding N-terminal domain 
of MDM2, well conserved in mammals, are thought to form a 
disordered segment that occludes the p53 binding site on MDM2 
in a pseudo-substrate, lid-like fashion; details however remain 
enigmatic.8 Based on biochemical data9 and NMR studies8 it 
was first hypothesized that upon stress, S17 that lies in this lid 
region (Fig. 1 and Sup. Fig. 1), gets phosphorylated by DNA-PK 
(DNA-dependent protein kinase) and interacts with high affin-
ity with the region surrounding the MDM2 cleft and that this 
would inhibit the p53-MDM2 interaction. NMR studies have 
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revealed that the apo-form of MDM2 is in a distinct conforma-
tion compared to ligand bound MDM2 and revealed that the 
lid can exist in several interconverting dynamic conformations 
in the ligand-free state.10 NMR also suggested a set of residues 
in MDM2 that appear to respond to the presence of the negative 
charge at position 17 (in the form of a phosphomimetic S17D); 
of these, H96 and K98 are the residues likely to be involved in 
charge-charge interactions with D17, which results in the occlu-
sion of the pocket of MDM2 from p53.8,11 However, despite 
the fact that NMR can be used to form predictions on how the 
phospho-mimetic lid inhibits the formation of the MDM2-p53 
complex, associated experimental data in vitro or in vivo has been 
limited.
Enzymological studies12 have since shown that the phospho-
mimetic S17D can promote the binding of p53 to MDM2, and 
can increase the ubiquitination of p53 in vitro. These enzymo-
logical studies contrast to the predictions based on NMR and was 
rationalized through modeling which suggested that D17 forms 
a salt bridge (SB) with R97 and K98, both of which are located 
on the surface of MDM2 but away from the binding pocket. 
This could lock the lid in a conformation that keeps the binding 
pocket ‘open’. Consistent with this, phospho-mimetic lid muta-
tion also increases the thermostability of the N-terminal domain 
of MDM2 in the presence of Nutlin or p53-mimetic peptides.13 
This is in contrast to the NMR derived hypothesis that the 
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on the same MDM2 domain indicated that no conformational 
change occurred upon ligand binding.11 Molecular dynamics 
(MD) simulations based on the crystal structure of MDM2 offer 
the potential to provide novel insight into how the lid undergoes 
complex dynamics depending on its phosphorylation state. The 
difference between an Asp (or Glu) mimicking phosphorylation, 
and an actual phosphate group is that the former is planar and 
carries a net charge of -1 while the latter is tetrahedral and car-
ries a net charge of -2 (normally). This would immediately sug-
gest differences in the lifetimes and strengths of interactions with 
charged residues. Indeed, recent simulation studies combined 
with experiments have shown that these two could give rise to sig-
nificant differences.15,16 In order to probe these differences in the 
MDM2-p53 system, we carried out detailed molecular dynamics 
simulation studies and provide hypotheses than can lead to novel 
experimental approaches to study MDM2 regulation. We have 
simulated the wild type (WT), S17D and the pS17 states of p53 
binding domain of MDM2 (residues 1–119) with the lid in ‘open’ 
and ‘closed’ conformations (see Fig. 1) which have been listed in 
Table 1 with their notations used in the following text.
Results and Discussions
WT. The lid region [MCNTNMSVPT
10
 DGAVTTSQIP
20
 
ASEQ
24
] is Ser-Thr rich and has two anionic residues (D11 
and E23). The p53 binding cleft of MDM2 is largely positively 
charged with several cationic residues in its vicinity (K51, K64, 
R65, K70, K94, R97, K98; see Sup. Fig. 2) and it is clear that this 
region can attract the negatively charged lid, albeit some parts 
of it. Aromatic residues F19/W23 of the TA domain of p53 (See 
Sup. Fig. 3) have been established as the main drivers of the high 
negative charge on the lid (either through phosphomimetic or 
through phosphorylation) would lock the lid on top of the active 
site and prevent p53 from binding. We still do not know whether 
in vivo the phospho-mimetic MDM2 lid is more or less active 
towards p53.
The function of the lid of MDM2 is thus being tackled by 
a combination of structural biology, biophysics, NMR, enzy-
mology and cell biological analyses. The lid function is not yet 
resolved and for example, it is not known how phosphorylation 
would actually change MDM2 conformation since the NMR 
and enzymological studies assumed that the phosphomimetic 
lid mutation represents what occurs when S17 is phosphorylated 
(pS17). Contrasting observations have also been obtained from 
NMR experiments; for example one study of the N-terminal 
domain of MDM2 suggested striking changes in MDM2 con-
formation upon ligand binding,14 whilst another NMR study 
Figure 1. two different structures from the NMR ensemble showing the closed (left) and open (right) conformation of MDM2’s lid; placing the p53 
peptide into MDM2’s binding cleft shows that steric occlusion is the reason why the ‘closed’ conformation cannot accommodate p53 whereas the 
‘open’ conformation can; MDM2’s cleft (green) & lid (magenta), p53 (red); few important residues are highlighted with different colors.
Table 1. List of notation used for the trajectories
Open Closed
Open 
(helix)
Closed 
(helix)
Wt-MDM2 Wto Wtc Wtohx Wtchx
S17-phosphorylated S17po
S17pc1, 
S17pc2
S17pohx S17pchx
S17D mutant S17Do S17Dc S17Dohx S17Dchx
tM tmc tmo x x
First row indicates lid conformations, including the cases where 21–24 
modeled as an α-helix. First column refers to the Wt and mutant 
systems. tM is the triple mutant ‘S17D, R97S, K98p’. trajectories after 
swapping of the side chains (S17p/D17), termed as S17p2D and D2S17p 
(not listed) which has been discussed in the text. See movies in SI.
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(and short peptides as is apparent from our simulations) such as 
nutlin to bind.
We further model the region 21–24 at the C-terminal end of 
the lid as α-helical (based on experimental observations10), and 
find that it remains stable for 10 ns. Three salt bridges stabilize 
the lid: D11-K94 (during 0–1 ns), E23-R97 (during 0–2 ns) 
and D11-R97 (during 7.5–10 ns) (Fig. 3 and see Movie M1c-d), 
including a very transient (<0.5 ns) E25-K51 interaction. In the 
presence of the helical conformation, D11 initially interacts with 
K94. However, the dynamics of the lid are associated with rapid 
rearrangements leading to the collapse of the lid onto the surface. 
By ~1.2 ns, the E23-R97 salt bridge is broken and Y100 begins 
to flip out of its closed state. Finally the helix undergoes a shift 
as Y100 makes stabilizing interactions with D23, while R97 is 
stabilized by D11. E25 and K51 are both solvent exposed. The 
flipping out of Y100 leads to an active site that is more open than 
in the non-helical lid considered above. Figure 3B shows how 
this conformation can easily bind both p53 and nutlin.
pS17. Phosphorylation of S17 in WTc was investigated 
by running two separate simulations: S17pc1 and S17pc2. In 
S17pc1, initially the phosphate group is hydrated and is stabi-
lized by hydrogen bonds (HB) to T16. Although the simulation 
started with the lid in a ‘closed’ conformation, there is an initial 
transient ‘opening’ that leaves the active site largely accessible, 
but by ~4 ns the active site is completely occluded by the lid and 
by ~8.5 ns, K51 moves towards the phosphate group at S17 and 
forms a salt bridge that remains stable until the end of 20 ns 
(Fig. 4 and Movie M2b-c). D11 forms a salt bridge with K94 
while R97 forms a salt bridge with E114 which lies in the 
C-terminal tail. E23 and E25 remain hydrated. In the other 20 ns 
simulation (S17pc2), the lid undergoes rapid rearrangements by 
7 ns and now the phosphate at S17 makes a salt bridge with K94 
(Fig. 4). This is accompanied by interactions with the side chains 
of H96 and Y100, with the latter undergoing a transition to 
affinity interaction between this domain of p53 and the hydro-
phobic p53 binding cleft of MDM2,3,17 and it is noteworthy that 
the lid lacks aromatic side chains. Thus the lack of a suitable 
anchor in the lid results in its high mobility even when it covers 
the pocket, as is clear from the simulations (see Movie M1a-b). 
In one particular region of its conformational space, the lid is 
held to the cleft by K94-D11 (stable ~5 ns) (Sup. Fig. 4) and 
R97-E23 salt bridges (stable ~14 ns) and hydrophobic interac-
tions between I19 and the cluster of L54, H96 and Y100 of the 
MDM2 cleft; the lid lies over the binding pocket, which remains 
closed. Interestingly, simulation studies had suggested that this 
cluster is responsible for mediating the binding of p53.4 In yet 
another region of the conformational space of the lid, the K94-
D11 interaction is replaced as the K94 side chain coordinates the 
backbone and side-chains of other residues such as N3, N5 etc., 
and the D11 is stabilized by Y67 and Q72 for another 1.5 ns, 
after which it gets exposed to solvent. The breaking of the K94-
D11 interaction results in the lid moving away from the surface 
(see Movie M1b) leaving the p53 binding site accessible to the 
solvent. This is accompanied by the rearrangement of a few resi-
dues around the binding pocket (L54, M62, Y67, H96 and Y100) 
that cover the opening of the pocket (Sup. Fig. 5) and appear to 
occlude the hydrophobic pocket from water molecules. The R97-
E23 interaction seems to enable the association of the A21-Q24 
region against the cleft that packs Y100 (together with H96, M62 
and Y67) and breaks at ~14 ns after which the lid remains exposed 
to solvent for another ~2 ns, when it folds on itself. At this stage 
the binding cavity appears to be sufficiently exposed for small 
molecules such as ‘nutlin’18 to bind (Fig. 2) although the gate-
keeper Y100,4 remains in the closed conformation; nevertheless 
the binding site is open enough for initial encounter complexes 
to form.19,20 This now provides a molecular picture behind the 
experimental observations11,13 whereby the presence of the lid can 
occlude MDM2 from binding p53 and yet allow small molecules 
Figure 2. (A) Snapshots from the Wtc trajectory showing a lid conformation that clashes with a p53 peptide (red) but can allow the small molecule in-
hibitor ‘nutlin’ (purple) to bind (built by superimposing MDM2-p53/nutnil complexes from pDB: 1YCR & 1RV1); (B) Snapshot from the Wtchx trajectory 
showing how the binding of both peptide and small molecule nutlin is possible.
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are apparent from our simulations, a feature that has also been 
reported earlier20).
WTc showed a transition of the lid from a closed state to an 
open state during the simulation, suggesting a very weak associa-
tion; however the transition from open to closed state was not 
observed for either WTc and WTo (see Movie M1a-d) the tim-
escale of this equilibrium exists in the millisecond regime.11 In 
contrast, for S17pc1&2, the lid opens during the first 1–2 ns but 
closes between 2–4 ns as the phosphate group localizes at K51 
or K94 (Fig. 4 and Movie M2b-c); this suggests that the phos-
phorylated lid clearly has a higher affinity for the cleft. When 
S17po was simulated, the phosphate forms salt bridges with R97 
or K98 (Sup. Fig. 8) leaving the binding pocket open to a ligand 
(Movie M2a). In summary, simulations suggest that when the 
lid is phosphorylated, it can adopt distinct conformations that 
are driven by salt bridging of the phosphate with (1) K51 (bind-
ing site is occluded), (2) K94 (binding site is occluded) and 
the “open state”4 by 9 ns. At this point, the active site remains 
very much open for binding to nutlin and possibly short helical 
peptides (but not p53, see Sup. Figs. 6 and 7); by 17 ns, R97 
also makes an interaction with the phosphate. This latter obser-
vation seems to be in accord with the experimental findings of 
Worrell et al.13 To get an estimate of the strength of the interac-
tion between the lid and the cleft upon phosphorylation (at S17), 
the -2e charge on the phosphate is switched off, and we find a 
110 kcal/mol destabilization in the electrostatic energy and a fur-
ther loss of ~286 kcal/mol of solvation energy, thus highlighting 
the strong electrostatic interactions between the phosphate and 
the MDM2 surface. Our results now build upon experimental 
observations,8,11 demonstrating that the lid is very flexible and not 
stabilized in any specific location on the cleft. This flexibility is 
necessarily attenuated upon phosphorylation as the lid will now 
preferentially be stabilized at the cationically dense regions of the 
cleft (Sup. Fig. 2) (at least two regions of the MDM2 surface 
Figure 3. Representative snapshots from Wtohx (left) and Wtchx (right) trajectories showing stabilizing interactions.
Figure 4. Snapshots from S17pc1 (left) and S17pc2 (right) trajectories show the salt bridge formation of pS17 with K51 and K94.
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during the first 4 ns but eventually the system stabilizes with the 
D17 located in the vicinity of K97/R98 (Fig. 5), as observed dur-
ing the last 2 ns of the total 10 ns trajectory. The binding site is 
open and can accommodate small molecules such as nutlin and 
p53 (Fig. 6 and Movie M3b). When the 21–24 region is mod-
eled as helical (Sup. Fig. 10), simulations (S17Dchx) show that 
the lid is stabilized in an open state with a D17-K51 and E25-
R97 salt bridges (lasts most of the simulation) and the active site 
can accommodate nutlin and p53 peptides. This brings together 
the observation that the 21–24 region may be helical as deter-
mined by NMR and that the S17D mutant binds peptides.12,13 
Simulation of S17D from the open state (S17Do, Movie M3a) 
shows that the loop can be stabilized either with R97 (4–8 ns) 
(3) R97/K98 (binding site is relatively exposed). The relative 
population of these two states (closed and open) in the phosphor-
ylated structure would determine the effect of phosphorylation 
on the equilibrium of the MDM2-p53 complex formation. If the 
21–24 region is helical, the phosphate is stabilized by K51 and the 
lid completely covers the binding site throughout the simulation 
(S17pchx, see Sup. Fig. 9 and Movie M2e). Additionally there 
may be as yet undiscovered protein partners that may regulate 
this; or as Worrall et al.12 have suggested, there may be allosteric 
effects of the interactions between the lid and the RING domain 
of MDM2 that have effects on ligand interactions.
S17D. Simulation of S17D started in the closed state (S17Dc) 
shows transient interactions of D17 with K51, H96 and K94 
Figure 5. Snapshots from the beginning (left) and end (right) of 10 ns of S17Dc, showing the instability of D17-K51 salt bridge leading to changes in lid 
conformation.
Figure 6. two different snapshots from S17Dc show that conformation of the lid leaves the binding pocket accessible to both p53 (red) and ‘nutlin’ 
(purple) (superimposed MDM2-p53/nulin complexes from pDB).
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simulations, that this apparent difference is resolved once we 
include the dynamical differences that result from phosphoryla-
tion and those that result from using a phosphomimetic. Our 
study was inspired by earlier successes in reproducing and suc-
cessfully predicting various features of the p53-MDM2 interac-
tion,4,19 and recent demonstrations that a phosphomimetic may 
display dynamical features that can be quite different from those 
displayed by a phosphate group.16
Simulations show that in the WT, the lid indeed has a weak 
affinity for the p53-binding cleft on the surface of MDM2, as pos-
tulated from the experiments. However the lid can also dynami-
cally span several conformational sub-states that can interconvert 
between open, semi open and closed states (however on the tim-
escales of the simulations we only see the closed to open transi-
tion), in agreement with NMR observations.8,11 Simulations show 
that associated with lid opening is rearrangements of side chains 
such as Y67, H96 etc., that can occlude the binding pocket; these 
sidechains can also undergo conformational changes in the pres-
ence of unbound (but associated through long range interactions) 
p53, which then enables p53 to bind.19 In a subsequent study,20 it 
was demonstrated that the “approach” of p53 and MDM2 is gov-
erned by a funnel shaped landscape that is strongly electrostatic in 
character (although at close range the van der Waals interactions 
dominate), originating largely in cationic residues surrounding 
the pocket of MDM2 (e.g., K51, K94, K98, etc.). While the resi-
dues K51 and K94 do not take part in interacting with p53 in its 
bound state, nevertheless they seem to play a significant role in 
attracting and orienting p53 for appropriate binding. This sug-
gests that if the lid has to prevent complex formation with p53, 
it could do so by attenuating the effects of these positive charges. 
We find in our current study that indeed, when S17 is phosphory-
lated, K51 and K94 interact strongly with the negatively charged 
phosphate. These residues are well conserved across the differ-
ent species (Sup. Fig. 12). This further suggests that the unit 
charge difference between the phosphomimetic (S17D) and the 
phosphate group (pS17) will lead to a greater degree of attenua-
tion by the latter. In addition, the tetrahedral geometry (Fig. 7) 
of the phosphate group is associated with a larger probability of 
maintaining salt bridge interactions. Indeed in our simulations, 
or with K51 (~10 ns). Again in the open state with 21–24 helical, 
D17 is stabilized either by R97 (~1.5 ns) or else remains hydrated 
with the binding site remaining open (see Movie M3c). Indeed, 
in the triple mutant TM (R97S, K98P, S17D)12 the above interac-
tions are absent and the lid tends to form a E25-K51 salt bridge as 
well as a less stable interaction between D17 and K51; in ‘TMo’ 
the lid moves away from the binding pocket leaving it completely 
open (see Sup. Fig. 11) and in ‘TMc’ also its shows large flexibil-
ity (see Movie M4a-b). To get an estimate of the strength of the 
interaction of the phosphomimetic with MDM2, if the charge of 
-1e on D17 is switched off, the electrostatic energy is destabilized 
by ~80 kcal/mol and the solvation energy by ~30 kcal/mol, which 
is much smaller in magnitude compared to that observed for the 
phosphate group.
MD simulations were carried out to investigate the dynamics 
of regulation of the p53-MDM2 interactions. This interaction 
is known to be under the regulation of phophorylations;2 how-
ever mechanistic details are incomplete although some insights 
have been obtained from modeling inspired mutagenesis stud-
ies.12,21,22 The lid domain of MDM2 has been implicated in this 
regulation, through the phosphorylation of S17. Earlier work8 
had hypothesized that under normal, unstressed conditions, the 
lid interacts weakly with the surface of MDM2 and is easily dis-
placed by p53 which is then bound by MDM2 and removed via 
the ubiquitination-proteasomal degradation pathway.1,2 Upon 
stress, the lid is phosphorylated at S17 and the newly acquired 
negatively charged phosphate group on the lid interacts strongly 
with residues on the MDM2 surface that lie in the vicinity 
of the p53 binding groove and occludes the groove from p53, 
which is then stabilized to carry out its function. This model 
was complicated by the observation that the lid can adopt con-
formations whereby it can occlude the groove from p53 and yet 
allow small molecules such as nutlin to bind.11 More recently, 
the work of Worrell et al. have added a new layer of complex-
ity to this picture by showing that upon phosphorylation (using 
a phosphomimetic) the lid can allow the binding of p53 and 
of nutlin.12,13 This at first glance appears to be in contrast to 
the biological picture where phosphorylation of the lid prevents 
p53 binding. However we now show, using molecular dynamics 
Figure 7. Representative snapshots showing the salt bridges between K51 and pS17/D17; the differences in interactions due to the tetrahedral/planar 
geometry of functional groups is clear.
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In summary, we show for the first time, using MD simula-
tions, how a flexible N-terminus “lid” region of MDM2 can 
regulate the p53-MDM2 interactions and how some of the dif-
ferences between various experimental observations can now be 
reconciled at the molecular level. These differences arise from the 
differing behavior of the flexible “lid” region depending on its 
chemical state when it is phosphorylated or when phosphoryla-
tion is being mimicked by using a phosphomimetic mutant. It 
also demonstrates for the first time the complex behavior of these 
systems and how subtle interactions defined by local differences 
in charge and geometry can modulate ligand binding/protein-
protein interactions. Further mutational studies will undoubt-
edly throw up additional complexities.
Methods
MD simulations were carried out on the p53 binding domain of 
MDM2 (residues 1–119) in its wild type (WT), S17D and the 
pS17 states with the lid in ‘open’ and ‘closed’ conformations (Fig. 
1). These states were modeled using the structures taken from the 
NMR derived structural ensemble of ‘apo’ MDM2 (RCSB code 
1Z1M).10 The NMR data also hinted at the presence of a tran-
sient α-helix10,11 across residues 21–24, and this was modeled too. 
Standard protocols4,19 using the CHARMM22 force field23 were 
applied to carry out MD simulations at 300 K in explicit water 
for 10 ns (listed in Table 1) with a few simulations extended to 
20 ns. This resulted in a total simulation time of ~200 ns. Details 
of the MD protocols have been provided in the supplementary 
information (SI).
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the S17D mutant shows weaker associations of the lid compared 
to those of S17p and as expected has a somewhat higher stability 
compared to WT. Due to the weaker association of S17D with 
K51 or K94, the lid appears to have a higher tendency to move 
towards the larger positive density presented by K97/R98. These 
result in a population shift towards the S17Do state characterized 
by salt bridges between D17 and K97/R98, which is in agreement 
with the observations of Worrell et al.12
It is clear from the simulations that the interactions of pS17 
are much more stable compared to those of D17. To further test 
this, we took representative snapshots from the simulations of 
pS17 and S17D (after the salt bridges with K51 had been sta-
bly formed) and carried out mutations whereby the pS17 was 
mutated to D17 and the D17 was mutated to pS17 (named as 
S17p2D and D2S17p respectively) and then continued the simu-
lations. As expected, for the pS17→D17, the interaction with K51 
is lost within a nanosecond, while for the D17→pS17 mutation, 
the salt bridge is maintained for 10 ns (See Movie M5a-b).
In effect, MD simulations show that the conformational 
ensembles that define the lid dynamics differ depending on the 
chemical state of the lid (S17D or phosphorylated S17). However, 
reconciliation of the contrasting observations that the S17D 
mutation appears to occlude p53 from binding (as observed in 
NMR), or can enable p53 to bind (enzymology) is more difficult. 
While simulations show that the chemically modified flexible 
lid can access regions of the conformational space that satisfies 
both observations (allow small molecules and peptides to bind 
and prevent longer peptides from binding), they also show that 
the S17D mutation does not appear to directly access conforma-
tions that a phosphorylated S17 does. This once again is a dem-
onstration that comparison of the two chemical states must be 
carried out with caution especially given the complexities that 
underlie protein-protein interactions. It is possible, as Worrell 
et al. (REF) point out, that the differences in the contrasting 
observations between NMR and enzymology may possibly arise 
from the fact that enzymology was carried out with full length 
MDM2, while the NMR data is derived from the Nterminal 
domain of MDM2. Models of the full length MDM2 are keenly 
awaited so that the mechanisms underlying allostery may be 
explored.
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